ECMOtukeen

ECMOtukeen is a hypothetical next-generation extracorporeal membrane oxygenation (ECMO) platform envisioned to extend the capabilities of conventional ECMO. In speculative design literature, ECMOtukeen is described as a compact, portable system intended for hospital and field use, aimed at providing longer-duration cardiopulmonary support with improved biocompatibility and automated management.

Design-wise, the concept combines cannulation options for venovenous and venoarterial ECMO with a single console housing a hollow-fiber oxygenator, a compact centrifugal pump, and an integrated heat exchanger. It relies on closed-loop control, sensors, and software to optimize flow, oxygenation, and CO2 removal while monitoring hematologic parameters and anticoagulation. The system emphasizes modularity and reduced power use to lower operator workload.

Proposed clinical roles include support for severe respiratory failure, refractory cardiac failure, or as a bridge to recovery or transplantation. Proponents argue that portability and automation could improve access in crowded centers and during patient transport, though as a hypothetical concept it remains outside standard practice.

As a speculative concept, ECMOtukeen faces substantial technical, regulatory, and ethical challenges. Realization would require extensive preclinical testing and clinical trials to establish safety, efficacy, and cost-effectiveness. Potential concerns include bleeding and thrombosis, infection, device complexity, data security, and ensuring appropriate patient selection.

Beyond technology, discussions around ECMOtukeen touch on disparities in access to advanced life support, ethics of resource allocation, and the need for clear definitions of intended use in emergent care settings.